Clear Labs
PrivateLast Round
Series D
Jan 13, 2025
Total Funding Raised
$130.5M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Clear Labs operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Series D round in January 2025.
Clear Labs is a biotechnology company that provides a fully automated, end-to-end next-generation sequencing platform for clinical and applied diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clear Labs Comparables
Compare Clear Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EW Group | 71% | |
| GenoScreen | 69% | |
| Rheonix | 69% |
For institutional investors. Book with your work email.
Clear Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jan 13, 2025 | ||||
| Series C | May 26, 2021 | ||||
| VC Round | May 14, 2020 | ||||
| Series B Extension | Oct 30, 2018 | ||||
| Series B | Dec 13, 2016 | ||||
Series A | Sep 15, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Clear Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series C, Series D, VC Round |
| GV | Series C, Series B, VC Round, Series D |
| NimbleVentures | Series D |
| Khosla Ventures | Series B Extension, Series C, Series B, VC Round, Series D, Series A |
| Morgan Stanley | Series D, Series C |
| Dentsu Ventures | Series B Extension |
| HBM Healthcare Investments | Series C, Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2026
Automating oncoReveal(R) Myeloid v2 and Essential MPN panels on Clear Dx(R) platform.
- Nov 10, 2026
Automating oncology testing panels on the Clear Dx platform with Pillar Biosciences.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withNov 10, 2026
Clear Labs, Inc. and Pillar Biosciences, Inc. expand their collaboration to automate the RUO oncoReveal(R) Myeloid v2 and Essential MPN panels on the Clear Dx(R) platform in California on Nov 10th '26.
For institutional investors. Book with your work email.
Clear Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Clear Labs's valuation, stock price, and market status.
Is Clear Labs a public or private company?
Clear Labs is a private company.
What is the current stock price of Clear Labs?
Clear Labs is a private company, so its shares have no public market price. Caplight tracks Clear Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Clear Labs worth (valuation)?
Valuation information for Clear Labs is not publicly available.
Can I buy Clear Labs stock?
Clear Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Clear Labs's last funding round?
Clear Labs's most recent funding round was Series D on January 13, 2025.
Who are the main investors in Clear Labs?
Key investors in Clear Labs include Redmile Group, Morgan Stanley, T. Rowe Price, Wing Venture Capital, Menlo Ventures.
Will Clear Labs IPO soon?
No public IPO plans have been announced for Clear Labs.
How can I track Clear Labs secondary market activity?
Caplight tracks bids, offers, and trades in Clear Labs's shares on secondary markets.